How many patents does
The United States Of America, As Represented By The Secretary have?
patents
2,239
families
214
granted
399
applications
1,840
US
442
EP
319
WO
289
JP
169
CN
106
KR
49
GB
1
RoW
864
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
The United States Of America, As Represented By The Secretary
Top ten assignees appearing on patents
2009 - 2018
| globeimmune | 80 |
| viamet pharmaceuticals | 41 |
| kite pharma | 35 |
| laboratoire hra pharma | 31 |
| afraxis holdings | 24 |
| admune therapeutics | 24 |
| bavarian nordic | 20 |
| advaxis | 18 |
| sanofi | 16 |
| auspex pharmaceuticals | 15 |
2018
| kite pharma | 19 |
| sanofi | 12 |
| globeimmune | 9 |
| advaxis | 5 |
| thermo fisher scientific | 5 |
| geneuro | 4 |
| viamet pharmaceuticals | 3 |
| convergene | 3 |
| novartis | 3 |
| transmural systems | 3 |
The United States Of America, As Represented By The Secretary
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| pak inhibitors for the treatment of cell proliferative disorders | 39 | 2011 |
| use of ulipristal for treating uterine fibroids | 39 | 2008 |
| yeast-brachyury immunotherapeutic compositions | 37 | 2011 |
| ratio based biomarkers and methods of use thereof | 35 | 2009 |
| substituted pyrazolopyrimidines as glucocerebrosidase activators | 32 | 2010 |
| methods and compositions for inducing protective immunity against filovirus infection | 28 | 2014 |
| yeast-muc1 immunotherapeutic compositions and uses thereof | 26 | 2011 |
| complexes of il-15 and il-15ralpha and uses thereof | 25 | 2007 |
| chimeric antigen receptors targeting b-cell maturation antigen | 24 | 2012 |
| listeria-based immunogenic compositions for eliciting anti-tumor responses | 23 | 2014 |